Research Article

Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population

Table 3

Distribution of IL-32 SNPs in SLE patients and healthy controls and their association with SLE susceptibility.

Modelrs28372698rs12934561
GenotypeControlsPatientsOR (95% CI) valueGenotypeControlsPatientsOR (95% CI) value

CodominantAA150 (0.484)69 (0.454)1.00 (reference)0.038 TT103 (0.332)63 (0.414)1.00 (reference)0.189
AT141 (0.455)63 (0.414)0.97 (0.64–1.47)TC149 (0.481)61 (0.401)0.67 (0.43–1.03)
TT19 (0.061)20 (0.132)2.29 (1.15–4.56)CC58 (0.187)28 (0.184)0.79 (0.46–1.37)
DominantAA150 (0.484)69 (0.454)1.00 (reference)0.545TT103 (0.322)63 (0.414)1.00 (reference)0.084
AT/TT160 (0.516)83 (0.546)1.13 (0.76–1.67)TC/CC207 (0.668)89 (0.586)0.70 (0.47–1.05)
RecessiveAA/AT291 (0.939)132 (0.868)1.00 (reference)0.011 TT/TC252 (0.813)124 (0.816)1.00 (reference)1.000
TT19 (0.061)20 (0.132)2.32 (1.20–4.50)CC58 (0.187)28 (0.184)0.98 (0.60–1.62)
OverdominantAA/TT169 (0.545)89 (0.586)1.00 (reference)0.411TT/CC161 (0.519)91 (0.6)1.00 (reference)0.108
AT141 (0.455)63 (0.414)0.85 (0.57–1.26)TC149 (0.481)61 (0.4)0.72 (0.49–1.07)
Allele
A441 (0.711)201 (0.661)1.26 (0.94–1.70)0.129T355 (0.573)187 (0.615)0.84 (0.63–1.11)0.217
T179 (0.289)103 (0.339)C265 (0.427)117 (0.385)

Notes. , the number of individuals. Statistically significant.